With AWS as its preferred cloud provider,
Gilead uses AWS machine learning and analytics to better inform
clinical trial design and advance data-driven decision making,
while prioritizing patient privacy and security
Gilead also transforms its enterprise resource
planning workloads on AWS to implement SAP S/4HANA across its
global business
Today, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc.
company (NASDAQ: AMZN), announced that Gilead Sciences, Inc.
(Nasdaq: GILD), a biopharmaceutical company advancing innovative
medicines to prevent and treat life-threatening diseases, has
selected AWS as its preferred cloud provider. Innovating on AWS and
with the help of AWS experts and partners in healthcare and life
sciences, Gilead provides its data scientists with the latest
advances in machine learning and analytics. These capabilities fuel
data-driven decision making across the organization—from biomarker
discovery through manufacturing and clinical trial recruitment—and
deliver insights that can help Gilead refine its drug pipeline. The
company also relies on AWS to host all workloads for its enterprise
resource planning (ERP) transformation project to implement SAP
S/4HANA.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20211129005047/en/
“With AWS as our preferred cloud provider, our researchers can
use AWS’s portfolio of services to gain the insights, agility, and
security needed to deliver new medicines at speed, and treat the
individual according to their unique needs, not just the disease,”
said Marc Berson, Senior Vice President and Chief Information
Officer at Gilead. “AWS’s performance, infrastructure, and scale
are the foundations on which we will complete our ERP
transformation and become a more efficient, agile, secure, and
data-driven business in the cloud.”
Gilead is reimagining its bioinformatics compute infrastructure
in the world’s leading cloud. The use of AWS’s compute, machine
learning, and database capabilities will support the analysis and
integration of diverse genomics, imaging, and experimental datasets
to support breakthroughs in how Gilead diagnoses and treats
diseases. For instance, by securely analyzing deidentified patient
genomic data at scale on AWS to reveal patterns, Gilead can uncover
insights on how people living with cancer respond to existing
therapeutic options, potentially accelerating the discovery of new
treatments.
Additionally, in its IT organization Gilead uses AWS to host all
workloads for its ERP transformation project to implement SAP
S/4HANA. These systems support business-critical processes in areas
such as supply chain, finance, operations, and commercial sales
across all therapeutic areas and business units. Running these
processes on AWS provides the foundation for Gilead’s
implementation of SAP S/4HANA. It also helps the company shorten
hardware refresh cycles, increase testing and deployment agility,
and gain visibility to improve business planning.
This is Gilead’s first implementation of production-scale ERP
systems in the cloud, and AWS provides the company’s IT
transformation team with scalable, secure, and high-performing
infrastructure. Working alongside AWS, Gilead will integrate its
SAP environments with a wide range of advanced AWS technologies in
areas such as analytics and machine learning, uncovering business
value and driving innovation. Moving forward, with AWS as the
foundation of its new cloud-based SAP environment, the company will
use a variety of Amazon Elastic Compute Cloud (Amazon EC2) instance
types, including X1 and X1e instances built for high-performance
databases, in-memory databases, and other memory-intensive
enterprise applications, to run ERP workloads more efficiently.
In addition, Gilead has moved more than 50% of its data center
footprint to AWS over the past 12 months through an accelerated
cloud migration program with AWS Professional Services. The company
also plans to migrate hundreds of applications to AWS, which
include critical applications that support industry good practices
(GxP) guidelines and regulations in areas like drug manufacturing,
storage, and distribution. As a result, Gilead is accelerating its
plans to upgrade its IT operations with AWS, while avoiding upfront
costs to refresh hardware and the sustained costs of running an
“always on,” on-premises IT landscape provisioned for peak use. As
an additional element of the migration, the company is building an
automated disaster recovery landscape in AWS. Doing so allows
Gilead IT to optimize and scale its disaster recovery processes in
the cloud to enhance resiliency.
With the help of AWS Professional Services and AWS experts in
healthcare and life sciences, Gilead research and development teams
are looking at ways to innovate in the cloud. They are taking an
agile product development approach that uses microservices to
optimize and automate operational processes throughout the company,
and constructing new data architectures to uncover new insights
more easily. Through the collaboration, Gilead aims to transform
priority areas like clinical program and study design, patient
experience, and centralized statistical adaptive monitoring, which
helps Gilead quickly identify and address potential issues related
to the management of clinical trials.
Gilead was also one of the first users of AWS for Health, an
offering of curated AWS services and AWS Partner Network (APN)
solutions now used by thousands of healthcare and life sciences
customers globally. AWS for Health provides proven and easily
accessible capabilities that help organizations increase the pace
of innovation, unlock the potential of health data, and develop
more personalized approaches to therapeutic development and care
across 16 critical solution areas in healthcare, genomics, and
biopharma.
“Gilead uses the proven performance of the world’s leading cloud
to innovate, scale, and deliver powerful therapies for diseases
like HIV and cancer, as well as advance standards for precision
medicine. By streamlining their IT operations with AWS and taking
advantage of our AWS for Health offerings, Gilead has the ability
to continuously refine its approach to clinical trials, drug
development, manufacturing, and distribution,” said Matt Garman,
Senior Vice President of Sales and Marketing at Amazon Web
Services, Inc. “AWS provides the security and privacy that
healthcare and life sciences companies need, as well as the
expertise and breadth and depth of services they can rely on to
build transformative healthcare solutions that enhance health and
wellbeing.”
About Amazon Web Services For over 15 years, Amazon Web
Services has been the world’s most comprehensive and broadly
adopted cloud offering. AWS has been continually expanding its
services to support virtually any cloud workload, and it now has
more than 200 fully featured services for compute, storage,
databases, networking, analytics, machine learning and artificial
intelligence (AI), Internet of Things (IoT), mobile, security,
hybrid, virtual and augmented reality (VR and AR), media, and
application development, deployment, and management from 81
Availability Zones within 25 geographic regions, with announced
plans for 27 more Availability Zones and nine more AWS Regions in
Australia, Canada, India, Indonesia, Israel, New Zealand, Spain,
Switzerland, and the United Arab Emirates. Millions of
customers—including the fastest-growing startups, largest
enterprises, and leading government agencies—trust AWS to power
their infrastructure, become more agile, and lower costs. To learn
more about AWS, visit aws.amazon.com.
About Amazon Amazon is guided by four principles:
customer obsession rather than competitor focus, passion for
invention, commitment to operational excellence, and long-term
thinking. Amazon strives to be Earth’s Most Customer-Centric
Company, Earth’s Best Employer, and Earth’s Safest Place to Work.
Customer reviews, 1-Click shopping, personalized recommendations,
Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing,
Kindle, Career Choice, Fire tablets, Fire TV, Amazon Echo, Alexa,
Just Walk Out technology, Amazon Studios, and The Climate Pledge
are some of the things pioneered by Amazon. For more information,
visit amazon.com/about and follow @AmazonNews.
About Gilead Sciences, Inc. Gilead Sciences, Inc. is a
biopharmaceutical company that has pursued and achieved
breakthroughs in medicine for more than three decades, with the
goal of creating a healthier world for all people. The company is
committed to advancing innovative medicines to prevent and treat
life-threatening diseases, including HIV, viral hepatitis and
cancer.
For more than 30 years, Gilead has been a leading innovator in
the field of HIV, driving advances in treatment, prevention and
cure research. Gilead researchers have developed eleven HIV
medications, including the first single tablet regimen to treat HIV
and the first once-daily oral antiretroviral tablet for
pre-exposure prophylaxis (PrEP) to reduce the risk of acquiring HIV
infection. These advances in medical research have helped to
transform HIV into a preventable, chronic condition for millions of
people. Gilead is committed to continued scientific innovation to
provide solutions for the evolving needs of people affected by HIV
around the world. Through partnerships and collaborations, the
company also aims to improve education, expand access and address
barriers to care, with the goal of ending the HIV epidemic for
everyone, everywhere.
Gilead operates in more than 35 countries worldwide, with
headquarters in Foster City, California.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211129005047/en/
Amazon.com, Inc. Media Hotline Amazon-pr@amazon.com
www.amazon.com/pr
Amazon.com (NASDAQ:AMZN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amazon.com (NASDAQ:AMZN)
Historical Stock Chart
From Apr 2023 to Apr 2024